![Overcoming hypoxia-induced functional suppression of NK cells](https://immunitybio.com/wp-content/uploads/2020/04/pub-med.jpg)
![Overcoming hypoxia-induced functional suppression of NK cells](https://immunitybio.com/wp-content/uploads/2020/04/pub-med.jpg)
NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly-Informed Integrated Immunotherapy Combining Innate High-Affinity Natural Killer (haNK) Cell Therapy with Adenoviral & Yeast-based Vaccines and Immune Checkpoint Inhibitor to Induce T-Cell Responses in Subjects with TNBC Who Have Progressed on or after Standard-of-Care Therapy
Mechanisms of resistance to T cell-based immunotherapy in head and neck cancer
Interaction kinetics with transcriptomic and secretory responses of CD19-CAR natural killer-cell therapy in CD20 resistant non-hodgkin lymphoma
![Efficient ADCC killing of meningioma by avelumab and a high-affinity natural killer cell line, haNK](https://immunitybio.com/wp-content/uploads/2019/10/JCI.jpg)